Transesophageal echocardiography (TEE) has become an essential tool in the management of critically ill patients, particularly when transthoracic echocardiography is insufficient. Its use allows to obtain high-quality imaging to assess cardiac function, diagnose the cause of shock, monitor fluid responsiveness, and evaluate venous congestion. It is especially valuable in complex scenarios such as stroke, the postoperative period after cardiac surgery, ECMO support, and during cardiac arrest, as it provides continuous visualization without interrupting chest compressions. Although it is a semi-invasive technique, it has a very favorable safety profile when performed by trained intensivists. Adequate training, including supervision and simulation, is crucial for achieving competence. Besides, TEE allows the examination of pulmonary and abdominal structures, extending its utility beyond the heart. Its incorporation into Intensive Care Medicine has demonstrated significant clinical impact, modifying therapeutic management in a high proportion of patients.
La ecocardiografía transesofágica (ETE) se ha convertido en una herramienta esencial en el manejo del paciente crítico, especialmente cuando la ecocardiografía transtorácica resulta insuficiente. Su uso permite obtener imágenes de alta calidad para evaluar la función cardíaca, diagnosticar causas de shock, monitorizar la respuesta a fluidos y valorar la congestión venosa. Es especialmente útil en escenarios complejos como el ictus, postoperatorio de cirugía cardíaca, el soporte con ECMO y durante la parada cardiorrespiratoria, ya que ofrece visualización continua sin interrumpir las compresiones. Aunque es una técnica semi-invasiva, presenta un perfil de seguridad muy favorable cuando es realizada por intensivistas entrenados. La formación adecuada, incluyendo supervisión y simulación, es clave para alcanzar competencia. Además, la ETE permite explorar estructuras pulmonares y abdominales, ampliando su utilidad más allá del corazón. Su incorporación en los Servicios de Medicina Intensiva ha demostrado impacto clínico significativo, modificando conductas terapéuticas en un alto porcentaje de pacientes.
Transesophageal echocardiography (TEE) is considered an advanced competence of ultrasound in critically ill patients.1,2 Training in TEE assessment, especially in patients on invasive mechanical ventilation (IMV), requires less professional capacitation than that required in the cardiology imaging laboratory. It can be reasonably achieved within 30−35 supervised scans,2–4 which can be further reduced if simulators are used as part of the training.5
The intensivist is frequently confronted with obstacles that hinder adequate imaging by transthoracic echocardiography (TTE), such as the patient's body type, the presence of wounds, dressings, drains, edema, IMV, or intra-abdominal hypertension.6 When TTE proves insufficient, TEE can provide very valuable anatomical and hemodynamic information through a systematic, goal-directed approach.6,7 TEE offers a unique view of the heart’s structure and function, enabling identification of the circulatory failure mechanisms in complex scenarios such as the postoperative period after cardiac surgery or extracorporeal membrane oxygenation (ECMO). Additionally, TEE provides information on cardiac output (CO), response to fluids, biventricular function, and the presence of severe valvular heart disease. As a procedure, TEE is easy to initiate, reproducible, and less operator-dependent than TTE.8
The popularity of TEE in recent years is due to its greater availability in Departments of Intensive Care Medicine (DICMs). The performance of TEE in critical patients has been associated with changes in treatment in a significant number of cases, reaching 80% in some series9 and up to 40% of cases when performed alongside other advanced hemodynamic monitoring systems.10 These results are maintained when the procedure is performed by supervised trainee physicians.11 TEE findings obtained by intensivists, compared with TTE or TEE performed by cardiologists, show high accuracy for the main diagnoses (90-100%) and other relevant diagnoses (88–100%).12 Together with a very low complication rate,4 all this has led to the consolidation of TEE’s role in DICMs in recent years, as recognized in consensus documents of different European societies.13,14
Indications, contraindications, and safety of the procedureTEE in the critically ill patient is often performed on intubated individuals with respiratory support, under analgosedation, in an Intensive Care Unit (ICU) or a critical care area with similar medical equipment.11 To ensure the safety of the procedure, it is essential to understand the indications and contraindications of the technique, which are summarized in Table 1.14,15 For patients with relative contraindications, a personalized assessment of the risk-to-benefit ratio should be performed. If the decision is made to perform the procedure, certain precautions should be taken, such as limiting probe manipulation or avoiding advancing the probe beyond the mid-esophageal plane.15
Indications and contraindications for TEE in the critically ill patient.
| Indications | Contraindications |
|---|---|
| Absolute: |
| |
| Relative: | |
|
IABC: intra-aortic balloon counterpulsation; ECMO: extracorporeal membrane oxygenation; TEE: transesophageal echocardiography; TTE: transthoracic echocardiography.
The main risks of TEE stem from the possibility of mechanical injury to the upper airway or digestive tract during probe insertion and manipulation, as well as from the administration of analgesia and sedation.16 In critically ill patients, the risk of airway injury is significantly reduced when the probe is introduced under direct esophageal visualization using a laryngoscope or videolaryngoscope.17–19 The risks associated with analgesia and sedation are significantly reduced when patients are monitored and receive support from a team of experts in the management of the hemodynamic effects of the drugs used. Despite its semi-invasive nature, TEE in critically ill patients is a safe procedure, with a practically zero incidence of major complications (e.g., death or esophageal perforation), and a low incidence (2.6%) of minor complications (e.g., unintentional nasogastric tube removal, mild bleeding, transient hypotension or hypoxemia, or mild oropharyngeal laceration).20,21
Components and movements of the transesophageal echocardiography probeThe TEE probe consists of a rigid handle connected to a flexible axial shaft, numbered in centimeters. This feature facilitates orientation and safe insertion. The distal end of the shaft contains the transducer lens with piezoelectric crystals, which obtains the image and has multiplanar rotation capability. Probe movements are controlled from the handle using 2 wheels and 2 buttons. Most probes include a locking lever or button that allows the position to be fixed. The transducer handle, in turn, is connected to the ultrasound machine via a cable and connector (Fig. 1A).
The TEE probe requires 4 types of movement for imaging (Fig. 1B)15:
- •
The movement of advancing the tip of the transducer to a certain depth in the esophagus or stomach is referred to as "advancement". The opposite movement, i.e., withdrawing the transducer toward the oral cavity, is called "withdrawal".
- •
The rotational movement of the transducer within the esophagus, so that the piezoelectric crystal is directed toward the lung or the descending aorta, is called "turning". Turning can be to the right (clockwise) or to the left (counterclockwise).
- •
The transducer tip flexes using the control wheels on the handle. The larger wheel controls flexion along the anteroposterior axis, producing "anteflexion" and "retroflexion" movements. These movements guide the ultrasound beam similarly to the tilting movement in TTE. The smaller wheel, in turn, controls flexion along the right/left axis, with "right flexion" and "left flexion" movements. Advancement/withdrawal or right/left turning movements should be performed with the transducer tip in a neutral position (without anteflexion or retroflexion), to reduce the pressure in the esophagus and minimize the risk of injury.
- •
The piezoelectric crystal can be rotated from 0° to 180°degrees by means of the multiplanar rotation buttons located on the probe handle. This performs "forward rotation" (increasing degrees) and "backward rotation" (decreasing degrees) movements.
During the preparation phase, it must be ensured that the patient meets the conditions necessary for a safe and uncomplicated procedure. The patient's well-being and safety must be guaranteed after administering analgesia, sedation, and neuromuscular blockade (the latter if deemed necessary).15 It is advisable to have medication and equipment available to treat potential complications, such as cardiovascular instability or unintentional extubation.
The critically ill patient remains in the supine position during TEE, with the operator positioned at the patient’s side. For insertion, the probe is placed in the neutral position with the lever "unlocked", and water-soluble gel or lubricant is applied to the crystal.15 To ensure the integrity of the probe, it is advisable to insert a bite block between the patient’s dental arches. Then, the probe is introduced with the transducer crystal facing the floor of the mouth under esophageal vision. This reduces the risk of injury to the oropharynx and piriform fossa.18,19 The transducer should be advanced smoothly. Slight resistance might be noted when passing the cricopharyngeal muscle,7 but advancement should not be forced if it is not possible. After advancing 30−35 cm, the four cardiac chambers can be seen in the so-called mid-esophageal 4-chamber (ME-4C) view or plane. It is helpful to have an assistant hold the patient's orotracheal tube to prevent displacement during movement. The ultrasound equipment monitors the probe temperature. The study should be stopped if 40 °C is reached, in order to avoid thermal injury to the esophagus.
Exploration protocolThe exploration protocol in a critically ill patient is markedly different from that used in a cardiac imaging laboratory. Thus, while a standard cardiac exploration should contain at least 28 planes, according to the recommendations of the American Society of Echocardiography (ASE),15 most of the useful information in the critically ill patient can be obtained with shorter protocols of between 11 and 16 planes,22,23 reducing the number of planes used for detailed valvular assessment. Protocols have even been described that simplify image acquisition to only four planes, to prevent the intensivist from focusing on the complexity of the scan (basic versus advanced) and rather centering attention on the image acquisition modality that can best respond to the clinical question and needs of the patient (TTE versus TEE).7
In our experience, a basic 5-plane imaging protocol (ME-4C, ME-LAX, ME-bicava, TG-SAX PM, and dTG-5C), as detailed in Table 2 and Fig. 2, is excellent for becoming familiarized with the technique and answering many questions of interest in the critically ill patient. Intensivists who master this sequence can easily acquire skills to obtain another 5 complementary planes (ME-MC, ME-2C, ME DescAo SAX, ME RV In-Out, and ME AscAo SAX) (Table 3) or perform the intermediate or complete extension protocols described in the literature.15,22,23
Basic exploration sequence views of TEE in the critically ill patient.
| 2D image | Acquisition protocol | Visualized structures | Systematic interpretation |
|---|---|---|---|
| Mid-esophageal 4 chambers (ME-4C) | Atria |
| |
| Interatrial septum | |||
| Ventricles | |||
| Interventricular septum | ||
| Mitral valve (A3A2 and P2P1) | |||
| Tricuspid valve (septal and posterior leaflets) | |||
| Mid-esophageal long axis (ME-LAX) | Left atrium |
| |
| Left ventricle | |||
| LV and RV outflow tract | |||
| Mitral valve (P2–A2) | ||
| Aortic valve | |||
| Proximal ascending aorta | |||
| Mid-esophageal bicava (ME-bicava) | Left atrium |
| |
| Right atrium | |||
| Interatrial septum | |||
| Superior vena cava | ||
| Inferior vena cava | |||
| Transgastric short axis at papillary muscle level (TG-SAX PM) | LV (middle segments) |
| |
| Papillary muscles | |||
| VD (middle segments) | ||
| Deep transgastric 5-chambers (dTG-5C) | Left ventricle |
| |
| LV outflow tract | |||
| Right ventricle | ||
| Aortic valve, aortic root | |||
| Mitral valve |
ECMO: extracorporeal membrane oxygenation; TEE: transesophageal echocardiography; VTI: velocity-time integral; LVOT: left ventricular outflow tract; RV: right ventricle; LV: left ventricle.
Basic and complementary sequence of the TEE study in critically ill patients: A) Schematic representation of the basic (yellow) and complementary (gray) sequences for TEE exploration in the critically ill patient. B) Nomenclature and basic anatomy of the views obtained in the basic and complementary exploration sequences.
Complementary exploration sequence views of TEE in the critically ill patient.
| 2D image | Acquisition protocol | Visualized structures | Systematic interpretation |
|---|---|---|---|
| Mid-esophageal at the level of the mitral commissure (ME-MC) | Left atrium |
| |
| Coronary sinus | |||
| Mitral valve (P3-A3A2A1-P1) | |||
| Left ventricle | ||
| Papillary muscles | |||
| Chordae tendineae | |||
| Mid-esophageal 2-chambers (ME-2C) | Left atrium |
| |
| Coronary sinus | |||
| Left appendage | |||
| Mitral valve (P3-A3A2A1) | ||
| Left ventricle | |||
| Circumflex artery | |||
| Mid-esophageal short axis of descending aorta (ME DescAo SAX) | Descending aorta |
| |
| |||
| Mid-esophageal right ventricle inflow tract - outflow tract (ME RV In-Out) | Atria |
| |
| Interatrial septum | |||
| Aortic valve | |||
| Right ventricular outflow tract | |||
| Tricuspid valve | ||
| Pulmonary valve | |||
| Pulmonary artery | |||
| Mid-esophageal short axis of ascending aorta (ME AscAo SAX) | Ascending aorta |
| |
| Pulmonary artery | |||
| Right pulmonary artery | ||
| Superior vena cava |
ECMO: extracorporeal membrane oxygenation; TEE: transesophageal echocardiography.
Obtaining a basic imaging protocol for characterizing a state of shock is one of the main indications for TEE in critically ill patients. The main objective is to identify disorders such as severe left or right ventricular dysfunction, severe valvular heart disease, pericardial effusion, or tamponade. Less frequent causes of shock include dynamic left ventricular outflow tract (LVOT) obstruction or extrinsic cardiac compression.21,24
In patients where the cause of shock is known, TEE can help to assess preload dependence and optimize the dosage of vasoactive and inotropic drugs. Monitoring CO requires measuring the LVOT diameter in mid-systole, in the mid-esophageal long-axis (ME-LAX) plane, and magnifying the image to improve accuracy (Fig. 3A). It also requires quantifying the velocity-time integral (VTI) of the LVOT (Fig. 3B), which is obtained in the deep transgastric 5-chamber (dTG-5C) plane.21,24 The calculation of CO requires averaging three consecutive beats when measuring the LVOT VTI. Estimating CO by TEE has the same limitations as in the case of TTE,25,26 fundamentally due to the assumption that the LVOT is a circumference (when in fact it is an oval), and from the possibility of underestimating or overestimating the measurement (due to deviation from the Doppler alignment axis or approximating the sample volume excessively towards the aortic valve, respectively). Consequently, error can be reduced by using the LVOT VTI exclusively to guide the therapeutic interventions. Additionally, the transvalvular aortic gradient can be assessed in this position. This provides information on flow dynamics and can detect dynamic LVOT obstruction when a dagger-shaped flow is observed (Fig. 3C). It also detects the presence of ascending aortic dissection as the cause of shock (Fig. 3D). Finally, diastolic function can be analyzed by studying the mitral filling pattern with pulsed Doppler in ME-4C.
Evaluation of volume responseTEE allows for the acquisition of preload parameters and the prediction of volume response. The presence of kissing walls and left ventricular (LV) obliteration identified in the transgastric short-axis plane at the level of the papillary muscles (TG-SAX PM) suggests severe hypovolemia, especially when associated with an LV end-diastolic area <10 cm2 (or <6 cm2/m2) (Fig. 3E).27
On the other hand, dynamic parameters such as a variation in peak aortic flow velocity in the LVOT > 12%, by pulsed Doppler, have been shown to be a good predictor of volume response in patients on IMV and without arrhythmias.28,29
Respirophasic variation of the superior vena cava (SVC) on its long axis, as measured in the mid-esophageal bicaval (ME-bicava) plane (Fig. 3F), is the most specific echocardiographic predictor of volume response. It surpasses the variation of the inferior vena cava (ΔIVC), the Δ LVOT VTI, and the variation of systolic volume.30–32 Vieillard-Baron et al.33 established a cut-off point of 36% (90% sensitivity [Se] and 100% specificity [Sp]) for Δ SVC ([diametermax − diametermin]/diametermax × 100) in patients subjected to IMV. A recently published study that included ventilated postoperative patients with tidal volume < 8 ml/kg identified a superior vena cava collapsibility index (SVC-CI) cut-off point Δ of 39.4% (Se 64% and Sp 92%).34 An SVC-CI > 37% on the short axis, obtained in the mid-esophageal ascending aorta short axis plane (ME AscAo SAX), was associated with volume response in postoperative cardiac surgery patients. Measurements obtained in M-mode in the ME-bicaval and ME AscAo SAX planes are taken at different anatomical sites and are therefore not interchangeable.35 Obtaining the ME AscAo SAX view presents less technical difficulty compared to the ME-bicava plane.
Assessment of systemic congestionThe study of systemic venous congestion using ultrasound is very useful for critically ill patients.36 In the context of TEE, information can also be obtained to complete the Venous Excess Ultrasound (VExUS) protocol, although the difficulty may be greater than with the abdominal study.37
The transesophageal VExUS study begins with the evaluation of the diameter of the IVC. From the ME-4C plane, the probe is rotated clockwise to focus on the right atrium (RA), and carefully advanced to visualize the cavoatrial junction, the IVC, and the confluence with the hepatic veins. Alternatively, the IVC can be assessed from the transgastric plane by flexing and rotating the probe clockwise.
The hepatic veins can be observed from both the distal esophageal plane, previously described, and from the transgastric plane. In this case, the probe is anteflexed and directed toward the RA starting at an angle of 0° and progressively adjusting between 0° and 60° (Fig. 4A). Once the vein is identified, the pulsed Doppler sample volume is placed at about 2−3 cm proximal to its confluence with the IVC, to evaluate hepatic blood flow (Fig. 4B).
Then, the portal vein is visualized from the deep transgastric plane by adjusting the angle between 20° and 60° (Fig. 4C). Color Doppler allows the identification of portal flow, which is directed upwards towards the transducer. The pulsed Doppler is then placed to assess the flow (Fig. 4D).
Although renal evaluation using TEE may be technically demanding in some patients, it is generally possible. Starting from the deep transgastric plane, the probe is rotated approximately 180° degrees until the descending aorta is visualized. Then, it is advanced slightly and rotated counterclockwise until the left kidney is identified (Fig. 4E). Alternatively, the kidney can be visualized in longitudinal section by maintaining a 90° angle and rotating the probe counterclockwise from the short-axis view of the descending aorta. Once the renal structure has been located, the pulsed Doppler is placed over an interlobar artery to record both the arterial and venous flow simultaneously (Fig. 4F).
Differential diagnosis of hypoxemiaIn critically ill patients, acute hypoxemia may be due to various cardiopulmonary conditions, so a differential diagnosis must be established quickly and accurately. In this context, TEE has established itself as a valuable diagnostic tool. This technique allows for the simultaneous evaluation of cardiac and pulmonary causes of hypoxemia, with high spatial resolution, independent of lung parenchyma or intestinal gas interference.
In cases of refractory hypoxemia, TEE is particularly useful for ruling out the presence of intracardiac shunts, such as patent foramen ovale (PFO) with a right-to-left shunt. This condition can be observed in patients with acute respiratory distress syndrome (ARDS) who require IMV support.38 For the identification of PFO using TEE, it is advisable to use the ME-bicaval plane, centering the view in the fossa ovalis. Additionally, 9.5 ml of saline mixed with 0.5 ml of room air is injected through two syringes connected to a three-way valve to generate echocontrast (shaken saline microbubbles). The injection is considered successful if the entire RA is opacified by the contrast induced by the microbubbles. A significant PFO is defined as the passage of more than 10 bubbles within three heartbeats after RA opacification (Appendix B Video 1). This test also allows for the detection of intrapulmonary shunts, which are characterized by the late passage (>3 cycles) of bubbles through the pulmonary veins.39
In addition, TEE is useful when pulmonary thromboembolism is suspected, allowing the visualization of indirect signs such as dilatation and dysfunction of the right ventricle (RV) or thrombi located in the right chambers or pulmonary arteries.40 Right ventricular volume or pressure overload is diagnosed by assessing interventricular septal dynamics.41
The introduction of transesophageal lung ultrasound (TELU) has made it possible to expand the technique’s usefulness to analyzing the lung parenchyma, particularly in posterior zones.42 The degree of aeration has been associated with PO2/FiO2 and 28-day mortality.43 Although the technique may be more complicated, the semiology is similar to that of transthoracic ultrasound.44 The study is performed by means of a craniocaudal exploration of each hemithorax. Reference points for the apical, middle, and basal lung zones are identified by the left subclavian artery’s origin, and the left superior pulmonary vein’s origin, and the IVC’s origin, respectively (Fig. 5). From each of these reference points identified with the transducer at 0°, a rotation to 90° allows the lungs to be studied over a longitudinal axis. From the cardiac view, for the study of the left hemithorax, the probe should be rotated counterclockwise, obtaining a view that allows examination of the lung, pleura, diaphragm, spleen, and, occasionally, the left kidney. For the study of the right hemithorax, the probe is rotated clockwise, using the same technique described above, initially with the transducer at 0° and subsequently at 90°. This method explores the right hemithorax, including the pleural space, lung, diaphragm, and underlying liver.
Care during cardiac arrestCardiopulmonary resuscitation (CPR) guidelines recommend using TTE as a diagnostic tool during cardiorespiratory arrest (CA) to identify potentially reversible causes such as pneumothorax, cardiac tamponade, pulmonary thromboembolism, ischemic heart disease, or severe hypovolemia.45,46
TEE offers significant advantages during CPR because it provides real-time imaging without interrupting chest compressions. This facilitates identifying cardiac rhythm recovery and allows for optimized ECMO cannulation when indicated.47,48 Recent studies have shown that the area of maximum cardiac compression is not always located at the center of the thorax. The use of TEE allows for the precise targeting of compression maneuvers, thus increasing their efficacy.49
The use of echocardiography during CA has been shown to improve the prognosis, as it allows for continuous cardiac rhythm monitoring, detection of fine ventricular fibrillation, identification of intracardiac thrombi or pericardial effusion, and assessment of right and left ventricular function.50 Additionally, echocardiography is useful for differentiating between pulseless electrical activity (PEA), which is characterized by the absence of myocardial contraction, and pseudo-PEA, which is characterized by visible myocardial contraction despite the absence of a palpable pulse or effective arterial pressure. The recommended imaging planes during CPR are described in Table 4.
Echocardiographic study views during cardiopulmonary resuscitation.
| TEE window | Cardiac structures | Applications |
|---|---|---|
| ME-4C |
|
|
| ME-LAX |
|
|
| TG-SAX PM |
|
|
| ME-Bicava |
|
|
| ME-DescAo SAX |
|
|
RA: right atrium; LA: left atrium; CVC: central venous catheter; ECMO: extracorporeal membrane oxygenation; TEE: transesophageal echocardiography; VF: ventricular fibrillation; ME-4C: mid-esophageal 4-chamber; ME-DescAo SAX: mid-esophageal descending thoracic aorta short axis; ME-LAX: mid-esophageal long axis; CPR: cardiopulmonary resuscitation; IVS: interventricular septum; TG-SAX: transgastric short axis; LVOT: left ventricular outflow tract; IVC: inferior vena cava; SVC: superior vena cava; RV: right ventricle; LV: left ventricle.
TEE is an essential diagnostic tool during cardiac surgery51,52 and also in the immediate postoperative period.53 Its intraoperative use can contribute to improved clinical outcomes,54 and the technique can effectively complement postoperative hemodynamic assessment when used in conjunction with other monitoring systems.55
In the postoperative context of cardiac surgery, TEE’s main value lies in its ability to provide an immediate, accurate, and often conclusive hemodynamic and etiological assessment for clinical decision-making.
During hemodynamic evaluation, TEE allows visualization of ventricular function and interdependence (septal position, ejection fraction, and/or shortening fraction in ME-4C and TG-SAX PM), the estimation of stroke volume and volemia status, as described above, and detection of LVOT obstructions or dynamic gradients (ME-LAX or dTG-5C).
Regarding etiological evaluation or the assessment of possible complications, TEE can detect the presence of right ventricular dysfunction56 and segmental contractility alterations (ME-4C, ME-MC, ME-LAX, and TG-SAX PM), particularly in coronary revascularization surgery. TEE can also detect the presence of pericardial effusion (Appendix B Video 2) with or without evidence of tamponade (ME-4C, ME-LAX and TG-SAX PM), and signs of prosthetic dysfunction or dehiscence (Appendix B Videos 3 and 4) (Table 5).53
Structures and evaluation parameters in the ECMO patient with transesophageal echocardiography.
| Structure | Parameter | View | Phase |
|---|---|---|---|
| Left ventricle | Myocardial size and thickness | ME-4C | Pre-implantation |
| Septal position | |||
| Presence of echocontrast/thrombi | |||
| Ejection fraction | TG-SAX PM | Assist | |
| Segmental mobility | |||
| Mitral S-wave (TDI) | dTG-5C | Withdrawal |
| Speed and magnitude VTI of LVOT | |||
| E/A ratio of transmitral flow | |||
| TDE of mitral flow | ME-4C | Post-implantation | |
| E/e' ratio of mitral annulus | |||
| Mitral and aortic valves | Diagnosis and quantification of insufficiency and/or stenosis | ME-4C | Pre-implantation |
| ME-2C | |||
| ME-MC | Assist | ||
| ME-LAX | |||
| Left atrium | Size and volume | ME-4C/ME-2C | Assist |
| ME-MC | |||
| Pulmonary vein flow | ME-LAX | ||
| Right ventricle | Ratio ofRV/ LV end-diastolic area | ME-4C | Pre-implantation |
| Septal position and movement | |||
| Ventricular geometry | |||
| Eccentricity index | |||
| Myocardial thickness | |||
| TAPSE | TG-SAX PM | Assist | |
| Tricuspid S' wave (TDI) | |||
| Shortening fraction | |||
| McConnell's sign | |||
| Tricuspid flow E/A ratio | |||
| TG-5C | Withdrawal | |
| ME-4C | Post-implantation | ||
| Tricuspid and pulmonary valves | Tricuspid insufficiency for sPAP estimation | ME RV In-Out | Pre-implantation |
| Assist | |||
| Right atrium | Area | ME-4C | Pre-implantation |
| Structures (valves, Chiari, coronary sinus) | |||
| Septal integrity (foramen ovale) | ME RV In-Out | Assist | |
| RA-LA shunt (color doppler ± shaken serum test) | ME-Bicava | Post-implantation | |
| Inferior/superior vena cava | Size and respiratory variation | ME-Bicava | Pre-implantation |
| Position of cannulas | Assist | ||
| Thrombi | Post-implantation | ||
| Aorta | Thrombosis/atheromatosis/dissection | ME-LAX | Pre-implantation |
| ME-DesAo SAX | Assist | ||
| Post-implantation | |||
| Pericardium/pleura | Effusion (characteristics and grade) | ME-4C | Assist |
| ME-2C | |||
| ME-LAX | Post-implantation | ||
| TG-SAX PM |
ECMO: extracorporeal membrane oxygenation; VTI: velocity-time integral; LVOT: left ventricular outflow tract; RV: right ventricle; LV: left ventricle.
ECMO and ventricular assist devices (VADs) have become established tools in cardiac intensive care medicine.57 They are essential in cases of severe heart and/or respiratory failure, in which TEE is a critical diagnostic technique.25,58,59
In the case of veno-arterial (VA) ECMO in particular, where many conventional hemodynamic monitoring systems are not validated, TEE has become consolidated as the cornerstone for patient evaluation and follow-up.60–63 TEE enables immediate assessment at the patient’s bedside, with a high diagnostic capacity. However, its correct use requires the intervention of adequately trained professionals with specific experience in this clinical context.64,65
Using a systematic exploration protocol allows TEE to assess the anatomy and function of the cardiopulmonary system before implantation. It also guides the insertion and proper positioning of the cannulas, optimizes circulatory flow according to the clinical conditions, performs dynamic monitoring to detect complications or hemodynamic changes, supervises support removal, and evaluates the heart’s structural and functional state after removal (Fig. 6) (Table 5).62,63,66,67
TEE is useful for a wide range of diagnoses, including patient-related aspects and the technique employed.68 It has proven effective in multiple scenarios, including implantation in patients with SARS-CoV-2 infection,69 situations of refractory CA oriented to the use of ECMO,70 or as a guide for specific ECMO configurations, the insertion of other devices, and the performance of invasive procedures.68,69,71,72
Cardiac evaluation as a source of systemic embolismIn patients with stroke, it is essential to investigate a possible cardiac cause as the source of cerebral embolism.73 The presence of intracardiac thrombi in the left atrium and appendage should be excluded in the ME-2C view, especially in patients with atrial fibrillation or atrial dysfunction, and in the LV in patients with ischemic heart disease or dilated cardiomyopathy. However, the LV apex is best analyzed with TTE. As previously described, the presence of PFO should be evaluated, especially in patients under 60 years of age with cryptogenic stroke.74 Similarly, the heart valves must be carefully assessed in all planes to rule out signs of endocarditis (Appendix B Video 5) and the presence of intracardiac tumors. Finally, it is advisable to complete the study by exploring the ascending aorta and aortic arch to detect ulcerated or mobile plaques measuring more than 3 mm in size.75,76
ConclusionsTEE is a valuable tool for evaluating critically ill patients. It can be used for diagnosis, hemodynamic monitoring, and performing invasive procedures. This technique goes beyond cardiac assessment to also include the pulmonary parenchyma and abdominal vein flow. It becomes an extension of the patient’s daily clinical examination. Continuous training and competency assessment of intensivists are essential to optimize performance and prevent complications.
CRediT authorship contribution statementVFG, DPT, LMV, LZ, and AO designed the study, reviewed the literature, drafted the manuscript, participated in the design of the tables and in the recording of the figures, and reviewed the final version of the manuscript. VFG, DPT, LMV, LZ, and AO participated in the design of the tables and in the recording of the figures. VFG, DPT, LMV, LZ, and AO reviewed the final version of the manuscript. All authors read and approved the final manuscript.
Declaration of Generative AI and AI-assisted technologies in the writing processNo artificial intelligence tools were used in the drafting of the manuscript or the creation of the tables and figures. Several databases were used for the literature search, mainly PubMed. For insertion of the literature citations, the Mendeley reference manager has been used, numbering and citing the different manuscripts analyzed for the writing of the article.
Financial supportThe authors declare that they have not received funding for this work.
The authors declare that they have no conflicts of interest.






















